Position
Fidelity in Sarepta Therapeutics, Inc.
Back to the book · All holders of SRPT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3.16M$1.13 → $3.27
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.47M | $1.65M | — | — | — | 0.0% |
| Q1 2026 | 1.47M | $1.65M | $1.13 | $262 | −$2.54K | 0.0% |
| Q2 2026 | 1.73M | $5.67M | $3.27 | $3.16M | $859.6K | 0.0% |